01.05.2012
1. ABOUT BOEHRINGER INGELHEIMThe Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours. In 2011, Boehringer Ingelheim achieved net sales of about 13.2 billion euros, while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.
Leaders in the area of respiratory medicine, with its chronic obstructive pulmonary disease (COPD) treatment Spiriva®, Boehringer Ingelheim is also making significant contributions to research in cardiometabolic, CNS, neurological and immunology / infectious diseases.